Accomplished C-Level executive, with experience in fund raising, strategy development and new company formation. Solid experience creating strategies to launch disruptive technologies. Demonstrated success in enhancing shareholder value during times of tremendous ambiguity. Diverse experience across big pharma, service organizations and start-ups, which contributes to expert problem resolution across various situations.

Bill has more than 25 years of experience in the pharmaceutical and life science industry. During 18+ years at Pfizer, he was responsible for activities spanning the entire drug development continuum including development and validation of cell-based assays. More recently, Bill worked in a contract research organization where he served as Director of immunoassay and biomarker services and Director of Business Development. Bill holds a M.S. (Micr

Dr. Cohen is a pharmaceutical industry expert at the intersection of drug discovery, personalized medicine and genomic technologies with 25+ years of experience. Most recently, Dalia served as the CSO at Asterand and Rosetta Genomics. During the four years at Rosetta, she led product development and the launch of three cancer diagnostics. Prior to Rosetta, she was employed at Novartis and Sandoz in several senior executive positions.